Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Breast Neoplasms

abstract

  • The doses of chemotherapy used to treat breast cancer, especially early breast cancer, should not be reduced if the maximal benefit is to be achieved.

publication date

  • May 5, 1994

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 8080512

Additional Document Info

start page

  • 1253

end page

  • 9

volume

  • 330

number

  • 18